Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chemotherapy-induced myelosuppression.

M B Maxwell¹, K E Maher

¹Department of Nursing, VA Medical Center, Portland, OR 97207.

Seminars in Oncology Nursing

|May 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Radiation therapy for prostate cancer.

Seminars in oncology nursing·2001

Same author

Organ preservation.

Seminars in oncology nursing·1999

Same author

Non-physician practitioners in radiation oncology: advanced practice nurses and physician assistants.

International journal of radiation oncology, biology, physics·1999

Same author

Stem cell transplantation in advanced breast cancer.

The American journal of nursing·1998

Same author

A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension.

American journal of hypertension·1994

Same author

Cancer of the prostate.

Seminars in oncology nursing·1993

Same journal

Boundary Erosion in Oncology Nursing: Psychosocial Consequences and Coping Strategies-A Qualitative Study.

Seminars in oncology nursing·2026

Same journal

Health-Related Quality of Life in Cancer Cachexia: Validation of the Turkish Version of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT).

Seminars in oncology nursing·2026

Same journal

A Dyadic Study of Lived Experiences of Family Stress, Emotional Distress and Family Resilience Among Women With Cancer During Pregnancy and Their Partners.

Seminars in oncology nursing·2026

Same journal

Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.

Seminars in oncology nursing·2026

Same journal

Refining Genomic Integration in Hereditary Breast Cancer: Reflections on Clinical and Nursing Implications.

Seminars in oncology nursing·2026

Same journal

Bridge Symptoms Between Symptom Clusters in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy: A Network Analysis.

Seminars in oncology nursing·2026

See all related articles

Chemotherapy-induced myelosuppression, a serious cancer treatment side effect, has seen limited success with past interventions. New hematopoietic growth factors offer potential benefits, but their precise clinical application requires further definition.

Area of Science:

Oncology
Hematology

Background:

Chemotherapy-induced myelosuppression is a frequent, severe complication of cancer therapy.
Existing methods to mitigate myelosuppression have shown minimal efficacy.

Purpose of the Study:

To evaluate the potential of novel hematopoietic growth factors in managing chemotherapy-induced myelosuppression.
To highlight the need for defined clinical guidelines for growth factor application.

Main Methods:

Review of current literature on chemotherapy-induced myelosuppression.
Analysis of emerging data on hematopoietic growth factors.

Main Results:

Hematopoietic growth factors demonstrate promise for patients undergoing myelotoxic chemotherapy.

Related Experiment Videos

Current data suggests potential benefits, but further research is needed.

Conclusions:

Novel hematopoietic growth factors represent a promising therapeutic avenue for chemotherapy-induced myelosuppression.
A cautious and evidence-based approach is essential for integrating growth factors into clinical practice.